Agena Bioscience
Targeted panels MassARRAY
MassARRAY ready-made and customized panels for pharmacogenetics, oncology and hereditary diseases
Agena’s targeted panels turn MassARRAY into a ready-made solution for pharmacogenetics, oncology, hereditary diseases, methylation and sample control – from a proven list of options to scalable analysis of large cohorts.
Request a quotationThe line includes ready-made research panels and the development of customized Assays by Agena kits. Among the current areas are VeriDose for pharmacogenetics, iPLEX HS and UltraSEEK for mutational profiling and liquid biopsy, HFE and CFTR for hereditary variants, as well as methylation and sample identification panels. Each card for each set of directories offers one point of choice for a clinical or research task.
Composition, multiplexity, required chemistry, sample type, number of reactions and RUO/IVD status are determined by the specific panel and region. Examples of the current portfolio are: VeriDose Core and DPYD Plus, HFE, iPLEX HS Lung, UltraSEEK Lung and research CFTR 100+ with coverage of more than 100 options. options, catalog number, compatibility with the MassARRAY configuration and regulatory status on the official manufacturer's page.
Prepared directions
- VeriDose Core and VeriDose DPYD Plus – Pharmacogenetic Panels
- iPLEX HS Lung and UltraSEEK Lung – mutational profiling and fluid biopsy in lung cancer
- HFE and research CFTR 100+ (more than 100 variants) – panels of inherited diseases
- Methylation and sample identification panels
Customized panels Assays by Agena
- Panel development for the customer’s task: from SNP and indelions to translocations, variations in the number of copies and methylation
- Functional verification of multiplexed sets in Agena laboratories before delivery
- Ready-to-use mixtures of oligonucleotides and data analysis software
Panel portfolio (examples)
| Parameter | Pharmacogenetics | Oncology/liquid biopsy | Hereditary diseases | methylation |
|---|---|---|---|---|
| Pharmacogenetics | VeriDose Core, VeriDose DPYD Plus | |||
| Oncology/liquid biopsy | iPLEX HS Lung, UltraSEEK Lung | |||
| Hereditary diseases | HFE, CFTR 100+ (research, over 100 variants) | |||
| Individual development | Assays by Agena – SNP, insertions/deletions, translocations, CNV, methylation |
Selection parameters
| Parameter | Pharmacogenetics | Oncology/liquid biopsy | Hereditary diseases | methylation |
|---|---|---|---|---|
| Defined by a specific panel | composition, multiplexity, required chemistry, sample type, number of reactions, RUO/IVD status |